Her main research concerns Internal medicine, Acquired immunodeficiency syndrome, Immunology, Viral load and Mortality rate. Her study looks at the intersection of Internal medicine and topics like Lentivirus with Cohort. The Acquired immunodeficiency syndrome study combines topics in areas such as Viral disease and Surgery, Prospective cohort study, Survival analysis.
Her Immunology study combines topics from a wide range of disciplines, such as Psychological intervention and Incidence. Her work investigates the relationship between Viral load and topics such as Cohort study that intersect with problems in HPTN 052, Treatment as prevention, Young adult and Retrospective cohort study. Benita Yip usually deals with Mortality rate and limits it to topics linked to Interquartile range and Population study.
Benita Yip focuses on Internal medicine, Acquired immunodeficiency syndrome, Immunology, Viral load and Sida. Her biological study spans a wide range of topics, including Surgery and Antiretroviral therapy. Benita Yip works mostly in the field of Acquired immunodeficiency syndrome, limiting it down to topics relating to Survival analysis and, in certain cases, Gerontology.
While the research belongs to areas of Immunology, Benita Yip spends her time largely on the problem of Protease inhibitor, intersecting her research to questions surrounding HIV drug resistance. Benita Yip has included themes like Regimen, Cohort study, Univariate analysis and Intensive care medicine in her Viral load study. Her Sida research includes elements of Chemotherapy and Immunopathology.
Her scientific interests lie mostly in Internal medicine, Acquired immunodeficiency syndrome, Cohort, Cohort study and Proportional hazards model. Her Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology and Ritonavir. As a member of one scientific family, she mostly works in the field of Acquired immunodeficiency syndrome, focusing on Young adult and, on occasion, Incidence.
Her biological study deals with issues like Viral load, which deal with fields such as Long-term care and Lymphoma. Her Cohort study research is multidisciplinary, incorporating perspectives in Odds ratio, Observational study and Antiretroviral therapy. Her study in Mortality rate is interdisciplinary in nature, drawing from both Cancer, Lung cancer and Immunology.
Her primary areas of study are Young adult, Acquired immunodeficiency syndrome, Cohort, Internal medicine and Retrospective cohort study. Her Young adult study often links to related topics such as Viral load. Her work deals with themes such as Observational study, Gerontology, Cohort study, Coinfection and Prospective cohort study, which intersect with Viral load.
Her is doing research in Hazard ratio and Proportional hazards model, both of which are found in Internal medicine. Her Proportional hazards model study integrates concerns from other disciplines, such as Cancer, Lung cancer, Mortality rate and Immunology. The study incorporates disciplines such as Discontinuation, Incidence, Relative risk, Substance abuse and Pneumocystis jirovecii Pneumonia in addition to Retrospective cohort study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Improved Survival Among HIV-Infected Individuals Following Initiation of Antiretroviral Therapy
Robert S. Hogg;Katherine V. Heath;Benita Yip;Kevin J. P. Craib.
Rates of Disease Progression by Baseline CD4 Cell Count and Viral Load After Initiating Triple-Drug Therapy
Robert S. Hogg;Benita Yip;Keith J. Chan;Evan Wood.
Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study
Julio S.G. Montaner;Julio S.G. Montaner;Julio S.G. Montaner;Viviane D. Lima;Viviane D. Lima;Rolando Barrios;Benita Yip.
The Lancet (2010)
Barriers to Use of Free Antiretroviral Therapy in Injection Drug Users
Steffanie A. Strathdee;Anita Palepu;Peter G. A. Cornelisse;Benita Yip.
Predictors of HIV Drug-Resistance Mutations in a Large Antiretroviral-Naive Cohort Initiating Triple Antiretroviral Therapy
P. Richard Harrigan;Robert S. Hogg;Winnie W. Y. Dong;Benita Yip.
The Journal of Infectious Diseases (2005)
Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up.
Robert S Hogg;Katherine Heath;David Bangsberg;Benita Yip.
Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 x 10(9) cells/L.
Evan Wood;Robert S. Hogg;Benita Yip;P. Richard Harrigan.
Annals of Internal Medicine (2003)
Decline in deaths from AIDS due to new antiretrovirals.
Robert S Hogg;Michael V O'Shaughnessy;Nada Gataric;Benita Yip.
The Lancet (1997)
Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens.
R. S. Hogg;B. Yip;C. Kully;K. J. P. Craib.
Canadian Medical Association Journal (1999)
Adherence to triple therapy and viral load response.
Sophie Low-Beer;Benita Yip;Michael V. O'Shaughnessy;Robert S. Hogg.
Journal of Acquired Immune Deficiency Syndromes (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: